Vicarious Surgical (RBOTW) Income from Non-Controlling Interests (2020 - 2021)

Vicarious Surgical (RBOTW) reported Income from Non-Controlling Interests of -$21.0 million for Q2 2021, down 78652.22% year-over-year from N/an in Q2 2020, and down 78652.22% on a QoQ basis from -$26704.0 in Q2 2020.

Vicarious Surgical (RBOTW) has 2 years of Income from Non-Controlling Interests data on file, last reported at -$21.0 million in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 6.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -2.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -5.85 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 22.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 100,000.00
10 Vicarious Surgical - - - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2021 -21.03 Mn
Jun 30, 2020 -26,704.00